We are live on ! Find out more
WTA

Washington Trust Advisors Portfolio holdings

AUM $1.24B
1-Year Est. Return 22.58%
This Fund
S&P 500
This Quarter Est. Return
+12.63%
1 Year Est. Return
+22.58%
3 Year Est. Return
+71.21%
5 Year Est. Return
10 Year Est. Return
AUM
$1.23B
AUM Growth
+$105M
Cap. Flow
-$5.93M
Cap. Flow %
-0.48%
Top 10 Hldgs %
40.45%
Holding
656
New
16
Increased
150
Reduced
147
Closed
21

Sector Composition

Rank Sector Weight
1 Technology 20.09%
2 Industrials 12.77%
3 Communication Services 12.53%
4 Healthcare 12.1%
5 Consumer Discretionary 11.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SIRI icon
601
SiriusXM
SIRI
$10.7B
$2.44K ﹤0.01%
106
CNTA
602
DELISTED
Centessa Pharmaceuticals
CNTA
$2.42K ﹤0.01%
184
WGS icon
603
GeneDx Holdings
WGS
$1.84B
$2.4K ﹤0.01%
26
AVTR icon
604
Avantor
AVTR
$8.48B
$2.23K ﹤0.01%
166
+29
+21% +$397
PEB icon
605
Pebblebrook Hotel Trust
PEB
$2.2B
$2.23K ﹤0.01%
223
DAWN
606
DELISTED
Day One Biopharmaceuticals
DAWN
$2.22K ﹤0.01%
342
CMRC
607
Commerce.com Inc Series 1
CMRC
$264M
$2.22K ﹤0.01%
444
SAIL
608
SailPoint Inc
SAIL
$8.95B
$2.17K ﹤0.01%
+95
New +$1.79K
TDW icon
609
Tidewater
TDW
$3.71B
$2.17K ﹤0.01%
47
NEO icon
610
NeoGenomics
NEO
$1.74B
$2.15K ﹤0.01%
294
BSY icon
611
Bentley Systems
BSY
$10.9B
$2.02K ﹤0.01%
37
PCVX icon
612
Vaxcyte
PCVX
$7.88B
$1.98K ﹤0.01%
61
SNDX icon
613
Syndax Pharmaceuticals
SNDX
$1.74B
$1.96K ﹤0.01%
209
RYAAY icon
614
Ryanair
RYAAY
$31.1B
$1.9K ﹤0.01%
+33
New +$1.68K
GLSI icon
615
Greenwich LifeSciences
GLSI
$197M
$1.81K ﹤0.01%
200
JANX icon
616
Janux Therapeutics
JANX
$915M
$1.8K ﹤0.01%
78
CYTK icon
617
Cytokinetics
CYTK
$10.8B
$1.62K ﹤0.01%
49
NRDY icon
618
Nerdy
NRDY
$110M
$1.49K ﹤0.01%
913
TTAM
619
Titan America SA
TTAM
$3.25B
$1.49K ﹤0.01%
+119
New +$1.58K
CGON icon
620
CG Oncology
CGON
$6.41B
$1.27K ﹤0.01%
49
KMTS
621
Kestra Medical Technologies
KMTS
$1.4B
$1.19K ﹤0.01%
72
DYN icon
622
Dyne Therapeutics
DYN
$4.28B
$1.19K ﹤0.01%
125
TWST icon
623
Twist Bioscience
TWST
$5.51B
$1.18K ﹤0.01%
32
RPAY icon
624
Repay Holdings
RPAY
$344M
$988 ﹤0.01%
205
MRNA icon
625
Moderna
MRNA
$22.1B
$966 ﹤0.01%
35

Similar funds

Washington Trust Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, Washington Trust Advisors held 656 positions worth $1.23B, up 9.3% from $1.13B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Washington Trust Advisors's Q2 2025 filing shows 16 new, 150 increased, 147 reduced and 21 closed positions. Its largest new stake was Vanguard Short-Term Bond ETF: 7,063 shares worth $556K. The largest sale was PayPal, an estimated $2.35M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Industrials and Communication Services.

  • Washington Trust Advisors's largest Q2 2025 buy was Vanguard Short-Term Bond ETF: 7,063 shares worth $556K.
  • Washington Trust Advisors added most to Align Technology in Q2 2025, an estimated $2.07M increase.
  • Washington Trust Advisors's biggest Q2 2025 reduction was PayPal, cutting an estimated $2.35M.
  • Washington Trust Advisors fully exited Vanguard Large-Cap ETF in Q2 2025, selling an estimated $199K.
  • Washington Trust Advisors's ten largest holdings make up 40% of its $1.23B portfolio in Q2 2025.
  • Washington Trust Advisors opened 16 new positions and closed 21 in Q2 2025.
  • Washington Trust Advisors's portfolio value rose 9.3% quarter-over-quarter to $1.23B.

Based on Washington Trust Advisors's 13F filing for Q2 2025, filed 31 Jul 2025.